Protecting Kids from Pneumonia Salisbury MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Salisbury.

Dr. William Anthony Strott
(410) 749-8300
1205 Pemberton Dr Ste 102
Salisbury, MD
Specialty
Pediatrics

Dr. Marcus Sidney Shaker
Salisbury, MD
Specialty
Pediatrics

Dr. Gloria Ang Uy
(410) 742-6555
1113 Cotton Patch Is
Salisbury, MD
Specialty
Pediatrics

Alfred Conrad Kolls Jr, MD
(410) 742-2255
106 Pine Bluff Rd Ste 11
Salisbury, MD
Specialties
Pediatrics
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1952

Data Provided by:
Charles Brett Hofmann, MD
(410) 742-7682
301 Powell Ave
Salisbury, MD
Specialties
Pediatrics, Internal Medicine-Pediatrics
Gender
Male
Education
Medical School: Univ Of Md Sch Of Med, Baltimore Md 21201
Graduation Year: 1996

Data Provided by:
Lucy Y Evangelista, MD
105 Pine Bluff Rd
Salisbury, MD
Specialties
Pediatrics
Gender
Female
Education
Medical School: Univ Of Santo Tomas, Fac Of Med And Surg, Manila, Philippines
Graduation Year: 1962

Data Provided by:
Dr. Christina Taylor McShea
Salisbury, MD
Specialty
Pediatrics

Pemberton Pediatric Medicine
(410) 749-8300
1201 Pemberton Drive Suite 2B
Salisbury, MD
 
Sharon A McFayden Eyo, MD
(410) 749-8300
1205 Pemberton Dr Ste 102
Salisbury, MD
Specialties
Pediatrics
Gender
Female
Education
Medical School: Suny-Hlth Sci Ctr At Syracuse, Coll Of Med, Syracuse Ny 13210
Graduation Year: 1994

Data Provided by:
Dr. Hirut Felleke Degefu
Salisbury, MD
Specialty
Pediatrics

Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com